Skip to main content

Table 2 Median progression-free survival and overall survival by initial chemotherapy regimen

From: Comparison of first-line chemotherapy regimens for ovarian carcinosarcoma: a single institution case series and review of the literature

First line chemotherapy N Median PFS (95% CI) Median OS (95% CI)
No chemotherapy 3 1.3 (0.5–2.1) 1.3 (0.5–2.1)
Ifosfamide/Paclitaxel 7 8.0 (2.4–13.7) 19.0 (16.4–21.6)
Carboplatin/Paclitaxel 15 17.8 (4.0–31.6) 23.2 (22.0–24.4)
Ifosfamide/Cisplatin 4 13.0 (0.0–28.3) 20.6 (0.0–65.2)
Carboplatin/Cytoxan 1 13.4 (NA) 13.4 (NA)
Adriamycin/Cisplatin 1 213.2 (NA) 213.2 (NA)
Total 31 9.3 (3.7–14.9) 19.7 (15.7–23.6)